{"id":147287,"date":"2023-05-25T07:00:03","date_gmt":"2023-05-25T11:00:03","guid":{"rendered":"https:\/\/44.250.171.167\/?p=147287"},"modified":"2023-05-25T07:00:04","modified_gmt":"2023-05-25T11:00:04","slug":"suven-pharmaceuticals-ltd-q4fy23-results-out-net-profit-grows-by-35","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/suven-pharmaceuticals-ltd-q4fy23-results-out-net-profit-grows-by-35\/","title":{"rendered":"Suven Pharmaceuticals Ltd Q4FY23 results out, net profit grows by 35%"},"content":{"rendered":"\n<p>Suven Pharma is in the business of Contract development &amp; manufacturing organisation (CDMO), catering to the needs of global Pharma Industry. SPL engages in NCE molecule development and supply of intermediates. This is a high-value-add, high-margin business. SPL supplies intermediates for four molecules addressing rheumatoid arthritis, diabetes, depression and women\u2019s health. This segment makes up 78% of revenues. The company has a strong order book with new clients being consistently added. Most clients are the Big Pharma companies in Europe and the US. The company is looking to shift from Intermediate to API manufacturing and is in discussion with clients regarding this. The company has stated that it has the facilities for API manufacturing.<\/p>\n\n\n\n<ul class=\"wp-block-list\" id=\"block-e1c3118b-b96b-4158-b1a6-2a3396b840ce\"><li>Suven Pharmaceuticals Ltd reported Total revenue for Q4 FY23 of \u20b9369 Crore, up from \u20b9364 Crore year on year depicting a growth of 1.3%.<\/li><li>Total Expenses for Q4 FY23 of \u20b9215 Crore down, from \u20b9219 Crore year on year, a decline of 2%.\u00a0<\/li><li>Consolidated Net Profit of \u20b9124 Crore, up 35% from \u20b992 Crore in the same quarter of the previous year.\u00a0<\/li><li>The Earnings per Share is \u20b94.87, up 35% from \u20b93.6 in the same quarter of the previous year.<\/li><\/ul>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"512\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/11a28025-993f-4f83-94e0-6ccfd925ae9a-8-4-1024x512.png\" alt=\"\" class=\"wp-image-147294\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/11a28025-993f-4f83-94e0-6ccfd925ae9a-8-4-1024x512.png 1024w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/11a28025-993f-4f83-94e0-6ccfd925ae9a-8-4-300x150.png 300w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/11a28025-993f-4f83-94e0-6ccfd925ae9a-8-4-768x384.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/11a28025-993f-4f83-94e0-6ccfd925ae9a-8-4-1536x768.png 1536w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/11a28025-993f-4f83-94e0-6ccfd925ae9a-8-4-2048x1024.png 2048w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Suven Pharma is in the business of Contract development &amp; manufacturing organisation (CDMO), catering to the needs of global Pharma Industry. SPL engages in NCE molecule development and supply of intermediates. This is a high-value-add, high-margin business. SPL supplies intermediates for four molecules addressing rheumatoid arthritis, diabetes, depression and women\u2019s health. This segment makes up [&hellip;]<\/p>\n","protected":false},"author":1863,"featured_media":125269,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[392,5747],"tags":[10304,12104,10442],"class_list":["post-147287","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-earnings","category-healthcare-stocks","tag-api","tag-arthritis","tag-cdmo"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2021\/10\/Earnings-Coverage.jpg","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":151914,"url":"https:\/\/alphastreet.com\/india\/suven-pharmaceuticals-ltd-q1fy24-12-rise-in-profits\/","url_meta":{"origin":147287,"position":0},"title":"Suven Pharmaceuticals Ltd Q1FY24; 12% rise in Profits","author":"Chirag Gupta","date":"August 9, 2023","format":false,"excerpt":"Suven Pharma is in the business of Contract development & manufacturing organisation (CDMO), catering to the needs of global Pharma Industry. Financial Results: Suven Pharmaceuticals Ltd reported Revenues for Q1FY24 of \u20b9348.00 Crores up from \u20b9339.00 Crore year on year, a rise of 2.65%. Total Expenses for Q1FY24 of \u20b9195.00\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-415.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-415.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-415.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-415.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-415.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-415.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":156068,"url":"https:\/\/alphastreet.com\/india\/suven-pharmaceuticals-ltd-q2fy24-11-rise-in-profits\/","url_meta":{"origin":147287,"position":1},"title":"Suven Pharmaceuticals Ltd Q2FY24; 11% rise in Profits","author":"Chirag Gupta","date":"November 10, 2023","format":false,"excerpt":"Suven Pharma is in the business of Contract development & manufacturing organisation (CDMO), catering to the needs of global Pharma Industry. Financial Results: Suven Pharmaceuticals Ltd reported Revenues for Q2FY24 of \u20b9231.00 Crores down from \u20b9278.00 Crore year on year, a fall of 16.91%. Total Expenses for Q2FY24 of \u20b9145.00\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-141.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-141.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-141.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-141.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-141.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-141.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":167555,"url":"https:\/\/alphastreet.com\/india\/suven-pharmaceuticals-ltd-q3fy25-77-rise-in-profits\/","url_meta":{"origin":147287,"position":2},"title":"Suven Pharmaceuticals Ltd Q3FY25; 77% rise in Profits","author":"Chirag Gupta","date":"March 25, 2025","format":false,"excerpt":"Hyderabad based CDMO company that offers services to leading global pharmaceutical and fine chemical majors in their NCE development endeavours. From process research & development to late-stage clinical and commercial manufacturing we are committed to provide customers with products fulfilling customer needs and expectations. Financial Results: Suven Pharmaceuticals Ltd reported\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/4-13.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/4-13.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/4-13.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/4-13.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/4-13.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/4-13.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":162853,"url":"https:\/\/alphastreet.com\/india\/suven-pharmaceuticals-ltd-q4fy24-57-fall-in-profits\/","url_meta":{"origin":147287,"position":3},"title":"Suven Pharmaceuticals Ltd Q4FY24; 57% fall in Profits","author":"Chirag Gupta","date":"July 9, 2024","format":false,"excerpt":"Hyderabad based CDMO company that offers services to leading global pharmaceutical and fine chemical majors in their NCE development endeavours. From process research & development to late-stage clinical and commercial manufacturing we are committed to provide customers with products fulfilling customer needs and expectations. Financial Results: Suven Pharmaceuticals Ltd reported\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/07\/image-68.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/07\/image-68.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/07\/image-68.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/07\/image-68.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/07\/image-68.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/07\/image-68.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":164176,"url":"https:\/\/alphastreet.com\/india\/suven-pharmaceuticals-ltd-q1fy25-50-fall-in-profits\/","url_meta":{"origin":147287,"position":4},"title":"Suven Pharmaceuticals Ltd Q1FY25; 50% fall in Profits","author":"Chirag Gupta","date":"September 3, 2024","format":false,"excerpt":"Hyderabad based CDMO company that offers services to leading global pharmaceutical and fine chemical majors in their NCE development endeavours. From process research & development to late-stage clinical and commercial manufacturing we are committed to provide customers with products fulfilling customer needs and expectations. Financial Results: Suven Pharmaceuticals Ltd reported\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":142946,"url":"https:\/\/alphastreet.com\/india\/suven-pharmaceuticals-q3fy23-net-profit-drops-by-33-percent\/","url_meta":{"origin":147287,"position":5},"title":"Suven pharmaceuticals Q3FY23 net profit drops by 33 percent","author":"Chirag Gupta","date":"February 28, 2023","format":false,"excerpt":"The company has reported total income of INR 366.78 crores during the period ended December 31, 2022 as compared to INR 456.27 crores during the period ended December 31, 2021, depicting a fall of 19.6%. The company has posted net profit of INR 107.72 crores for the period ended December\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"earnings preview","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/147287","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1863"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=147287"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/147287\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/125269"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=147287"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=147287"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=147287"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}